• Something wrong with this record ?

Perceptions on basilar artery occlusion management in China versus other countries: Analysis of the after the BEST of BASICS (ABBA) survey

X. Huo, P. Klein, . Raynald, B. Drumm, Y. Chen, MM. Qureshi, WJ. Schonewille, X. Liu, W. Hu, X. Ji, C. Li, Y. Zhu, M. Abdalkader, D. Strbian, U. Fischer, V. Puetz, F. Alemseged, H. Yamagami, S. Sacco, G. Saposnik, P. Michel, ES. Kristoffersen, P....

. 2022 ; 31 (11) : 106804. [pub] 20221004

Language English Country United States

Document type Journal Article

INTRODUCTION: Uncertainty remains on the optimal management of basilar artery occlusion (BAO). Two large randomized controlled trials (RCTs) in 2019 and 2021 demonstrated neutral results with respect to the use of endovascular therapy (EVT) for BAO. This study aimed to understand regional variation in physicians' perceptions towards the treatment of BAO as stratified by physician respondents from China versus outside China, prior to the publication of studies demonstrating a benefit of EVT for BAO. METHODS: An international online survey was conducted of stroke neurologists and neurointerventionalists from January to March 2022. Survey questions evaluated physician opinions toward the use of EVT in BAO, as well as the clinical and imaging features underlying treatment decisions. Respondents were dichotomized as either from China or from other countries and differences between groups were analyzed. RESULTS: There were 1245 physician respondents across 73 countries of which 295 (23.7%) were from China. Compared to respondents from the rest of the world, respondents from China were more likely to be interventionalists (71.5% vs 35.0%; p < 0.0001). Overall, more than 95% of respondents believed that EVT was superior to medical therapy under certain circumstances. Chinese respondents were more likely to believe that further RCTs were necessary than respondents from other countries (93.6% vs 76.2%; p < 0.0001). Chinese respondents were more likely to use advanced imaging in later time windows and use a premorbid mRS threshold of ≤2 for BAO selection to EVT. CONCLUSION: Most stroke physicians believe EVT is beneficial in selected patients with BAO. Clinical and imaging modality differences were observed in the selection criteria used for EVT. There was greater inclination to enroll all trial eligible patients in a BAO RCT by respondents from China as compared to other parts of the world.

2nd Department of Neurology Attikon University Hospital National and Kapodistrian University of Athens Athens Greece

Cooper Neurological Institute Cooper University Hospital Camden NJ USA

Department fo Neurology Bern University Hospital University of Bern Switzerland

Department of Biotechnological and Applied Clinical Sciences University of L'Aquila Italy

Department of Emergency Xiangtan Central Hospital Xiangtan China

Department of Internal Medicine and Cardiology University Hospital Brno and Faculty of Medicine Masaryk University Brno Czech Republic

Department of Neurology Akershus University Hospital Lørenskog Norway

Department of Neurology Basel University Hospital University of Basel Switzerland

Department of Neurology Dresden Neurovascular Center Universitätsklinik Carl Gustav Carus Technische Universität Dresden Dresden Germany

Department of Neurology General Hospital of Northern Theater Command Shen Yang China

Department of Neurology Heidelberg University Hospital Heidelberg Germany

Department of Neurology Helsinki University Hospital and Helsinki University Helsinki Finland

Department of Neurology Klinikum Ludwigshafen Ludwigshafen Germany

Department of Neurology Linyi People's Hospital Linyi China

Department of Neurology Xuanwu Hospital Capital Medical University Beijing China

Department of Neurosurgery Xuanwu Hospital Capital Medical University Beijing China

Hospital de Clínicas de Porto Alegre Brazil

International Clinical Research Center and Department of Neurology St Anne's University Hospital and Faculty of Medicine Masaryk University Brno Czech Republic

Interventional Neuroradiology Beijing Tiantan Hospital Beijing China

Medicine and Neurology Melbourne Brain Centre at the Royal Melbourne Hospital University of Melbourne Parkville Victoria Australia

Neurology Boston Medical Center Boston University Chobanian and Avedisian School of Medicine MA

Neurology Federal University of Rio Grande do Sul Porto Alegre

Neurology Foshan Sanshui District People's Hospital Foshan China

Neurology Jinling Hospital Medical School of Nanjing University Nanjing China

Neurology Leuven University Hospital Leuven Belgium

Neurology Service Clinical Neurosciences Lausanne University Hospital and University of Lausanne Lausanne Switzerland

Neurology St Antonius Hospital Nieuwegein the Netherlands

Neurology University of Pittsburgh Medical Center USA

Neuroradiologie Interventionelle Centre Hospitalier de l'Universite de Montreal Montreal Canada

Radiation Oncology Boston Medical Center MA USA

Radiology Boston Medical Center Boston University School of Medicine Boston MA USA

Radiology Imperial College Healthcare NHS Trust Charing Cross Hospital London UK

Stroke Center and Department of Neurology The 1st Affiliated Hospital of the University of Science and Technology of China Division of Life Sciences and Medicine University of Science and Technology of China Hefei Anhui China

Stroke Center Bach Mai Hospital Hanoi Medical University Hanoi Vietnam

Stroke Medicine Imperial College Healthcare NHS Trust Charing Cross Hospital London UK

Stroke Neurology National Hospital Organization Osaka National Hospital Osaka Japan

Stroke Outcomes and Decision Neuroscience Research Unit Division of Neurology University of Toronto Toronto Canada

Universitätsklinikum Hamburg Eppendorf Klinik und Poliklinik für Neurologie Hamburg Germany

Vietnam National University of Medicine and Pharmacy Vietnam

Xinqiao Hospital and The 2nd Affiliated Hospital Army Medical University

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032804
003      
CZ-PrNML
005      
20230131151144.0
007      
ta
008      
230120s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jstrokecerebrovasdis.2022.106804 $2 doi
035    __
$a (PubMed)36206608
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Huo, Xiaochuan $u Interventional Neuroradiology, Beijing Tiantan Hospital, Beijing, China
245    10
$a Perceptions on basilar artery occlusion management in China versus other countries: Analysis of the after the BEST of BASICS (ABBA) survey / $c X. Huo, P. Klein, . Raynald, B. Drumm, Y. Chen, MM. Qureshi, WJ. Schonewille, X. Liu, W. Hu, X. Ji, C. Li, Y. Zhu, M. Abdalkader, D. Strbian, U. Fischer, V. Puetz, F. Alemseged, H. Yamagami, S. Sacco, G. Saposnik, P. Michel, ES. Kristoffersen, P. Sedova, R. Mikulik, JE. Siegler, K. Lobotesis, D. Roi, J. Demeestere, H. Han, G. Yuan, MD. Ton, HS. Chen, Q. Yang, Z. Qiu, SO. Martins, G. Tsivgoulis, G. Thomalla, S. Nagel, BCV. Campbell, TG. Jovin, RG. Nogueira, J. Raymond, S. Banerjee, TN. Nguyen, Z. Miao
520    9_
$a INTRODUCTION: Uncertainty remains on the optimal management of basilar artery occlusion (BAO). Two large randomized controlled trials (RCTs) in 2019 and 2021 demonstrated neutral results with respect to the use of endovascular therapy (EVT) for BAO. This study aimed to understand regional variation in physicians' perceptions towards the treatment of BAO as stratified by physician respondents from China versus outside China, prior to the publication of studies demonstrating a benefit of EVT for BAO. METHODS: An international online survey was conducted of stroke neurologists and neurointerventionalists from January to March 2022. Survey questions evaluated physician opinions toward the use of EVT in BAO, as well as the clinical and imaging features underlying treatment decisions. Respondents were dichotomized as either from China or from other countries and differences between groups were analyzed. RESULTS: There were 1245 physician respondents across 73 countries of which 295 (23.7%) were from China. Compared to respondents from the rest of the world, respondents from China were more likely to be interventionalists (71.5% vs 35.0%; p < 0.0001). Overall, more than 95% of respondents believed that EVT was superior to medical therapy under certain circumstances. Chinese respondents were more likely to believe that further RCTs were necessary than respondents from other countries (93.6% vs 76.2%; p < 0.0001). Chinese respondents were more likely to use advanced imaging in later time windows and use a premorbid mRS threshold of ≤2 for BAO selection to EVT. CONCLUSION: Most stroke physicians believe EVT is beneficial in selected patients with BAO. Clinical and imaging modality differences were observed in the selection criteria used for EVT. There was greater inclination to enroll all trial eligible patients in a BAO RCT by respondents from China as compared to other parts of the world.
650    _2
$a lidé $7 D006801
650    12
$a arteriální okluzní nemoci $x terapie $7 D001157
650    12
$a arteria basilaris $x chirurgie $7 D001488
650    12
$a endovaskulární výkony $x metody $7 D057510
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a cévní mozková příhoda $x terapie $7 D020521
650    _2
$a průzkumy a dotazníky $7 D011795
650    _2
$a výsledek terapie $7 D016896
650    _2
$a randomizované kontrolované studie jako téma $7 D016032
655    _2
$a časopisecké články $7 D016428
700    1_
$a Klein, Piers $u Radiology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA; Neurology, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, MA
700    1_
$a Raynald, $u Interventional Neuroradiology, Beijing Tiantan Hospital, Beijing, China
700    1_
$a Drumm, Brian $u Stroke Medicine, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK
700    1_
$a Chen, Yimin $u Neurology, Foshan Sanshui District People's Hospital, Foshan, China
700    1_
$a Qureshi, Muhammad M $u Radiology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA; Radiation Oncology, Boston Medical Center, MA, USA
700    1_
$a Schonewille, Wouter J $u Neurology, St. Antonius Hospital, Nieuwegein, the Netherlands
700    1_
$a Liu, Xinfeng $u Neurology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China; Stroke Center and Department of Neurology, The First Affiliated Hospital of the University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
700    1_
$a Hu, Wei $u Stroke Center and Department of Neurology, The First Affiliated Hospital of the University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
700    1_
$a Ji, Xunming $u Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China
700    1_
$a Li, Chuanhui $u Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China
700    1_
$a Zhu, Yuyou $u Stroke Center and Department of Neurology, The First Affiliated Hospital of the University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
700    1_
$a Abdalkader, Mohamad $u Radiology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA
700    1_
$a Strbian, Daniel $u Department of Neurology, Helsinki University Hospital and Helsinki University, Helsinki, Finland
700    1_
$a Fischer, Urs $u Department of Neurology, Basel University Hospital, University of Basel, Switzerland; Department fo Neurology, Bern University Hospital, University of Bern, Switzerland
700    1_
$a Puetz, Volker $u Department of Neurology, Dresden Neurovascular Center, Universitätsklinik Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
700    1_
$a Alemseged, Fana $u Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia
700    1_
$a Yamagami, Hiroshi $u Stroke Neurology, National Hospital Organization, Osaka National Hospital, Osaka, Japan
700    1_
$a Sacco, Simona $u Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Italy
700    1_
$a Saposnik, Gustavo $u Stroke Outcomes and Decision Neuroscience Research Unit, Division of Neurology, University of Toronto, Toronto, Canada
700    1_
$a Michel, Patrik $u Neurology Service, Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
700    1_
$a Kristoffersen, Espen Saxhaug $u Department of Neurology, Akershus University Hospital, Lørenskog, Norway
700    1_
$a Sedova, Petra $u International Clinical Research Center and Department of Neurology, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Mikulik, Robert $u International Clinical Research Center and Department of Neurology, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Siegler, James E $u Cooper Neurological Institute, Cooper University Hospital, Camden, NJ, USA
700    1_
$a Lobotesis, Kyriakos $u Radiology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK
700    1_
$a Roi, Dylan $u Radiology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK
700    1_
$a Demeestere, Jelle $u Neurology, Leuven University Hospital, Leuven, Belgium
700    1_
$a Han, Hongxin $u Department of Neurology, Linyi People's Hospital, Linyi, China
700    1_
$a Yuan, Guangxiong $u Department of Emergency, Xiangtan Central Hospital, Xiangtan, China
700    1_
$a Ton, Mai Duy $u Stroke Center, Bach Mai Hospital, Hanoi Medical University, Hanoi, Vietnam; Vietnam National University of Medicine and Pharmacy, Vietnam
700    1_
$a Chen, Hui-Sheng $u Department of Neurology, General Hospital of Northern Theater Command, Shen Yang, China
700    1_
$a Yang, Qingwu $u Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University
700    1_
$a Qiu, Zhongming $u Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University
700    1_
$a Martins, Sheila O $u Neurology, Federal University of Rio Grande do Sul, Porto Alegre; Hospital de Clínicas de Porto Alegre, Brazil
700    1_
$a Tsivgoulis, Georgios $u Second Department of Neurology "Attikon" University Hospital, National and Kapodistrian University of Athens, Athens, Greece
700    1_
$a Thomalla, Götz $u Universitätsklinikum Hamburg-Eppendorf, Klinik und Poliklinik für Neurologie, Hamburg, Germany
700    1_
$a Nagel, Simon $u Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany; Department of Neurology, Klinikum Ludwigshafen, Ludwigshafen, Germany
700    1_
$a Campbell, Bruce C V $u Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia
700    1_
$a Jovin, Tudor G $u Cooper Neurological Institute, Cooper University Hospital, Camden, NJ, USA
700    1_
$a Nogueira, Raul G $u Neurology, University of Pittsburgh Medical Center, USA
700    1_
$a Raymond, Jean $u Neuroradiologie Interventionelle, Centre Hospitalier de l'Universite de Montreal, Montreal, Canada
700    1_
$a Banerjee, Soma $u Stroke Medicine, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK
700    1_
$a Nguyen, Thanh N $u Radiology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA; Neurology, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, MA. Electronic address: Thanh.Nguyen@bmc.org
700    1_
$a Miao, Zhongrong $u Interventional Neuroradiology, Beijing Tiantan Hospital, Beijing, China. Electronic address: Zhongrongm@163.com
773    0_
$w MED00167194 $t Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association $x 1532-8511 $g Roč. 31, č. 11 (2022), s. 106804
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36206608 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151140 $b ABA008
999    __
$a ok $b bmc $g 1891500 $s 1184139
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 31 $c 11 $d 106804 $e 20221004 $i 1532-8511 $m Journal of stroke and cerebrovascular diseases $n J Stroke Cerebrovasc Dis $x MED00167194
LZP    __
$a Pubmed-20230120

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...